Marksans Pharma

BSE : 524404 | NSE : MARKSANS

Industry : Pharma Drugs | ISIN : INE750C01026 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)1,091.87
Net Worth (NW)805.21
Intrinsic Worth (IW)1,897.08
Market Cap (MC)2,482.49
Economic Value Added25.03
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)57.56%
IC Gross Margin (EBITDA/IC)22.34%
IC Net Margin (NPT/IC)14.18%
Knowledge Turnover (Sales/IC)1.13
Market to Intrinsic Value (MC/IW)1.31

As OfIntrinsic ValueMarket Price
31 Dec 2020Rs. 46.35Rs. 60.65
12 May 2021 - Rs. 75.40
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 74.48ReduceBuy on Dips
KB > 50% : Yes50 DMA : Rs. 59.94
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-18
C
199.39
199.32
3.99
-2.21
-5.68
-6.48
1.25
Jun-18
C
235.25
238.49
38.72
32.75
30.36
24.88
26.18
Sep-18
C
269.04
268.24
36.32
30.79
27.72
20.57
29.33
Dec-18
C
248.37
248.52
36.34
31.31
29.55
25.13
14.76
Mar-19
C
247.41
257.14
25.38
19.11
16.68
9.85
9.78
Jun-19
C
245.03
247.21
34.60
29.86
27.61
22.48
20.40
Sep-19
C
256.40
264.28
41.45
36.47
33.66
25.97
28.72
Dec-19
C
287.65
287.68
47.31
39.98
38.34
29.56
34.15
Mar-20
C
335.35
335.38
69.22
59.60
57.56
42.74
44.04
Jun-20
C
331.15
331.33
70.20
62.95
61.40
49.37
60.55
Sep-20
C
356.47
360.14
86.82
67.83
65.90
50.73
47.33
Dec-20
C
358.36
355.20
87.89
79.31
77.64
58.94
49.85
* C - Consolidated, S - Standalone